Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques
- PMID: 6127044
- DOI: 10.1097/00000542-198210000-00012
Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques
Abstract
To compare two methods of estimating the potency of neuromuscular relaxants of medium duration, the authors determined the potency of vecuronium (ORG NC45) using cumulative dose-response (CDR) techniques, and compared these data with published values from our group obtained using the single bolus technique. During 60% N2O-halothane anesthesia, patients received 10 micrograms/kg vecuronium; additional incremental doses of vecuronium, 5 micrograms/kg, were given when no change occurred in the height of three successive twitches. Using these dose-response data, the authors determined least-squares regression lines and ED20, ED50, and ED80. These results were compared to values obtained by the single bolus technique under comparable conditions. The CDR and single bolus technique yielded ED50 values of 19.9 and 15.0 micrograms/kg, respectively. All potency estimates by CDR were larger than those obtained by the single bolus dose technique. It was concluded that, for vecuronium, a medium duration neuromuscular relaxant, CDR yields potency estimates which are larger than those obtained by the traditional single bolus dose technique. Because the single bolus dose technique is the accepted method for construction of dose-response curves, the authors recommended that CDR not be used for potency determination of muscle relaxants of medium and short duration such as vecuronium.
Similar articles
-
Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method.Acta Anaesthesiol Scand. 1985 Jan;29(1):121-4. doi: 10.1111/j.1399-6576.1985.tb02171.x. Acta Anaesthesiol Scand. 1985. PMID: 2858146
-
Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.Anesthesiology. 1983 Jun;58(6):519-23. doi: 10.1097/00000542-198306000-00007. Anesthesiology. 1983. PMID: 6134483
-
Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.Anesthesiology. 1981 Jul;55(1):6-11. doi: 10.1097/00000542-198107000-00003. Anesthesiology. 1981. PMID: 6113794
-
Org-NC45: a new steroidal non-depolarizing muscle relaxant.Pharm Weekbl Sci. 1982 Feb 19;4(1):1-4. doi: 10.1007/BF02112349. Pharm Weekbl Sci. 1982. PMID: 6122196 Review.
-
Newer neuromuscular blocking agents: how do they compare with established agents?Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003. Drugs. 2001. PMID: 11434449 Review.
Cited by
-
Sensitivity to vecuronium in myasthenia gravis: a dose-response study.Can J Anaesth. 1990 Apr;37(3):301-6. doi: 10.1007/BF03005579. Can J Anaesth. 1990. PMID: 1969771
-
Pharmacodynamic behaviour of rocuronium in the elderly.Can J Anaesth. 1993 Feb;40(2):127-32. doi: 10.1007/BF03011309. Can J Anaesth. 1993. PMID: 8443851 Clinical Trial.
-
Vecuronium is more potent in Montreal than in Paris.Can J Anaesth. 1991 Sep;38(6):717-21. doi: 10.1007/BF03008448. Can J Anaesth. 1991. PMID: 1680573 Clinical Trial.
-
Neuromuscular blockade with vecuronium in paediatric patients with burn injury.Br J Clin Pharmacol. 1989 Aug;28(2):155-9. doi: 10.1111/j.1365-2125.1989.tb05408.x. Br J Clin Pharmacol. 1989. PMID: 2570602 Free PMC article.
-
Eliminating residual neuromuscular blockade: a literature review.Ann Transl Med. 2024 Aug 1;12(4):65. doi: 10.21037/atm-23-1743. Epub 2024 May 14. Ann Transl Med. 2024. PMID: 39118951 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources